Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease

被引:76
作者
Click, Benjamin [1 ]
Rivers, Claudia Ramos [1 ]
Koutroubakis, Ioannis E. [1 ]
Babichenko, Dmitriy [2 ]
Anderson, Alyce M. [1 ]
Hashash, Jana G. [1 ]
Dunn, Michael A. [1 ]
Schwartz, Marc [1 ]
Swoger, Jason [1 ]
Baidoo, Leonard [1 ]
Barrie, Arthur, III [1 ]
Regueiro, Miguel [1 ]
Binion, David G. [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Informat Sci, Pittsburgh, PA 15213 USA
关键词
inflammatory bowel disease; cost; depression; superuser; QUALITY-OF-LIFE; CROHNS-DISEASE; ULCERATIVE-COLITIS; COSTS; STRATEGIES; BURDEN; COHORT; RISK;
D O I
10.1097/MIB.0000000000000763
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Inflammatory bowel disease (IBD) is a heterogeneous chronic inflammatory condition requiring significant healthcare expenditure. Subgroups of individuals contribute disproportionately to spending. We aimed to determine demographic and clinical factors predictive of high healthcare expenditures for IBD patients followed over a multiyear period.Methods:This was a registry analysis using a prospective observational, consented, natural history registry from a tertiary IBD center and associated medical charges, not including pharmacy expenses. The 100 patients with the highest medical charges (top 5%) were compared with the median 300 patients. Logistic regression determined demographic and clinical factors associated with high charge patients.Results:IBD patients in the high charge group had significantly more unemployment (P < 0.0001), were of black race (P = 0.013), comorbid psychiatric illness (P = 0.002), hypertension (P = 0.01), diabetes (P = 0.004), opiate use (P < 0.0001), perianal involvement (P = 0.002), penetrating disease (P < 0.0001), and extensive colitis (P = 0.01). In multivariate analysis, unemployment (Crohn's disease [CD]: odds ratio [OR], 3.04; 95% confidence interval [CI], 1.32-7.02; ulcerative colitis [UC]: OR, 2.68; 95% CI, 1.20-5.99), psychiatric illness (UC: OR, 2.08; 95% CI, 1.03-4.19), opiates (CD: OR, 5.61; 95% CI, 2.67-11.82; UC: OR, 5.14; 95% CI, 2.52-10.48), prior surgery (CD: OR, 3.29; 95% CI, 1.59-6.82; UC: OR, 2.72; 95% CI, 1.39-5.32), penetrating CD (OR, 3.29; 95% CI, 1.02-10.62), and corticosteroid requirement (CD: OR, 3.78; 95% CI, 1.86-7.65; UC: OR, 2.98; 95% CI, 1.51-5.90) remained independently associated with high charges.Conclusions:High expenditure IBD patients were affected by more severe disease. The high prevalence of depression, anxiety, and chronic pain in these patients suggests the need for focused treatment of these comorbidities ultimately to reduce financial burden.
引用
收藏
页码:1442 / 1449
页数:8
相关论文
共 38 条
[1]   Effectiveness of Interventions Targeting Frequent Users of Emergency Departments: A Systematic Review [J].
Althaus, Fabrice ;
Paroz, Sophie ;
Hugli, Olivier ;
Ghali, William A. ;
Daeppen, Jean-Bernard ;
Peytremann-Bridevaux, Isabelle ;
Bodenmann, Patrick .
ANNALS OF EMERGENCY MEDICINE, 2011, 58 (01) :41-52
[2]   Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease [J].
Ananthakrishnan, A. N. ;
Gainer, V. S. ;
Perez, R. G. ;
Cai, T. ;
Cheng, S-C. ;
Savova, G. ;
Chen, P. ;
Szolovits, P. ;
Xia, Z. ;
De Jager, P. L. ;
Shaw, S. Y. ;
Churchill, S. ;
Karlson, E. W. ;
Kohane, I. ;
Perlis, R. H. ;
Plenge, R. M. ;
Murphy, S. N. ;
Liao, K. P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) :445-454
[3]   Permanent work disability in Crohn's disease [J].
Ananthakrishnan, Ashwin N. ;
Weber, Lydia R. ;
Knox, Josh F. ;
Skaros, Susan ;
Emmons, Jeanne ;
Lundeen, Sarah ;
Issa, Mazen ;
Otterson, Mary F. ;
Binion, David G. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (01) :154-161
[4]   Systematic review: the costs of ulcerative colitis in Western countries [J].
Cohen, R. D. ;
Yu, A. P. ;
Wu, E. Q. ;
Xie, J. ;
Mulani, P. M. ;
Chao, J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (07) :693-707
[5]  
Cohen RD, 2000, AM J GASTROENTEROL, V95, P524
[6]   Higher Levels of Knowledge Reduce Health Care Costs in Patients with Inflammatory Bowel Disease [J].
Colombara, Federica ;
Martinato, Matteo ;
Girardin, Giulia ;
Gregori, Dario .
INFLAMMATORY BOWEL DISEASES, 2015, 21 (03) :615-622
[7]  
Desilva S., 2009, Gut, V58, pA457
[8]  
Faust Alejandra H, 2012, Gastroenterol Hepatol (N Y), V8, P173
[9]  
Feagan BG, 2000, AM J GASTROENTEROL, V95, P1955
[10]  
Gandhi S, 2014, J CROHNS COLITIS, V8, P401, DOI 10.1016/j.crohns.2013.10.005